Home › High Blood Pressure › South Carolina
High Blood Pressure clinical trials in South Carolina
14 studies for High Blood Pressure are looking for participants at sites in South Carolina.
Cities in South Carolina
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Medical University of South Carolina, Charleston
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06059638A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Charleston
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07142356Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- OnSite Clinical Solutions, LLC, Fort Mill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07511361A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Monroe Biomedical Research - Charleston, North Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Piedmont Research Partners, LLC, Fort Mill
- Velocity Clinical Research-Gaffney-69046, Gaffney
- Tribe Clinical Research LLC - Greenville, Greenville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - Mauldin, Mauldin
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Charleston
- Research Site, Columbia
- Research Site, Orangeburg
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- MUSC, Mt. Pleasant
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891Improving the Collaborative Health of Adult Dyads
- University of South Carolina, Columbia
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05370014Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Columbia
- Clinical Trial Site, Greenville
- Clinical Trial Site, Greer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Global Paradise System US Post Approval Study
- Medical University of South Carolina, Charleston
- Prisma Health Richland Hospital, Columbia
- Spartanburg Regional Medical Center, Spartanburg
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Walker Family Care, Little River
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy
- University of South Carolina, Columbia
Recruiting
Ages 18 and older · Women · Updated May 4, 2026 · NCT07457970Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Charleston
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.